Insider trading

Period: 120 months Stock: DXCM Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

471 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

471 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

471 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

471 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
471 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
471 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

471 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2023
Dolan Matthew Vincent SVP Corporate Strategy-Develop
Sold, plan not stated
$264.85K 2,303 at 115.00
6.4%
14 Mar 2023
Stern Sadie EVP Chief Human Resources Offi
Sold, plan not stated
$43.96K 393 at 111.86
0.5%
13 Mar 2023
Dolan Matthew Vincent SVP Corporate Strategy-Develop
Sold, plan not stated
$661.96K 6,229 at 106.27
14.8%
13 Mar 2023
Flynn Paul R EVP Global Revenue
Sold, plan not stated
$295.64K 2,782 at 106.27
4.8%
13 Mar 2023
Regan Barry J. EVP Operations
Sold, plan not stated
$213.60K 2,010 at 106.27
2.8%
6 Mar 2023
Leach Jacob Steven EVP Chief Technology Officer
Sold, plan not stated 2×
$2.08M 18,144 at 114.74
6.1%
6 Mar 2023
Dolan Matthew Vincent SVP Corporate Strategy-Develop
Sold, plan not stated
$25.85K 226 at 114.40
0.8%
1 Mar 2023
SAYER KEVIN R President CEO and Chairman of
Sold, plan not stated 2×
$4.23M 38,464 at 109.94
10.4%
23 Feb 2023
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$46.00K 412 at 111.64
0.3%
22 Feb 2023
Sylvain Jereme M EVP Chief Financial Officer
Sold, plan not stated
$274.90K 2,400 at 114.54
3.6%
30 Jan 2023
SAYER KEVIN R President CEO and Chairman of
Sold, plan not stated 2×
$6.03M 56,844 at 106.15
13.3%
30 Jan 2023
Regan Barry J. EVP Operations
Sold, plan not stated
$234.84K 2,213 at 106.12
3.6%
23 Jan 2023
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$44.44K 412 at 107.86
0.3%
20 Jan 2023
SAYER KEVIN R President CEO and Chairman of
Sold, plan not stated
$4.82M 45,607 at 105.75
9.7%
23 Dec 2022
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$46.38K 412 at 112.57
0.3%
8 Dec 2022
Flynn Paul R EVP Global Revenue
Sold, plan not stated
$1.11M 8,988 at 123.50
13.9%
21 Nov 2022
Sylvain Jereme M EVP Chief Financial Officer
Sold, plan not stated
$270.29K 2,400 at 112.62
3.4%
1 Sep 2022
Dolan Matthew Vincent SVP Corporate Strategy-Develop
Sold, plan not stated
$408.15 5 at 81.63
0.0%
23 Aug 2022
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$84.21K 1,000 at 84.21
0.7%
25 Jul 2022
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$83.07K 1,000 at 83.07
0.7%
23 Jun 2022
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$72.55K 1,000 at 72.55
0.7%
6 Jun 2022
Sylvain Jereme M EVP Chief Financial Officer
Sold, plan not stated
$180.94K 600 at 301.57
3.3%
24 May 2022
Pacelli Steven Robert EVP Managing Director Dexcom V
Sold, plan not stated
$74.08K 250 at 296.33
0.7%
9 May 2022
Patterson Chad EVP Global Marketing
Sold, plan not stated
$266.33K 777 at 342.77
5.4%
25 Apr 2022
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$109.99K 250 at 439.94
0.7%
11 Apr 2022
Patterson Chad EVP, Global Marketing
Sold, plan not stated
$387.03K 776 at 498.75
5.1%
29 Mar 2022
Regan Barry J. EVP Global Operations
Sold, plan not stated
$553.00K 1,106 at 500.00
6.3%
23 Mar 2022
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$115.00K 250 at 459.98
0.7%
17 Mar 2022
Dolan Matthew Vincent SVP Corporate Development
Sold, plan not stated
$217.80K 484 at 450.00
6.8%
16 Mar 2022
Dolan Matthew Vincent SVP Corporate Development
Sold, plan not stated
$291.55K 686 at 425.00
8.8%
15 Mar 2022
SAYER KEVIN R Chairman, CEO & President
Sold, plan not stated 10×
$1.23M 3,000 at 409.77
3.0%
15 Mar 2022
Dolan Matthew Vincent SVP Corporate Development
Sold, plan not stated
$419.01K 1,016 at 412.41
11.5%
10 Mar 2022
Selvaraj Shelly Ramasamy SVP Chief Information Officer
Sold, plan not stated
$949.40K 2,366 at 401.27
17.1%
10 Mar 2022
Patterson Chad EVP, Global Marketing
Sold, plan not stated
$311.39K 776 at 401.27
4.8%
4 Mar 2022
Sylvain Jereme M EVP, Chief Financial Officer
Sold, plan not stated
$253.76K 600 at 422.94
3.9%
1 Mar 2022
Patterson Chad EVP, Global Marketing
Sold, plan not stated
$19.04K 46 at 413.97
0.4%
23 Feb 2022
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$98.58K 250 at 394.33
0.7%
14 Feb 2022
SAYER KEVIN R Chairman, CEO & President
Sold, plan not stated
$1.25M 3,000 at 418.04
3.1%
10 Feb 2022
KAHN BARBARA Director · indirect
Sold, plan not stated 15×
$2.06M 4,666 at 442.35
60.9%
Sold half or more
24 Jan 2022
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$104.19K 250 at 416.77
0.7%
18 Jan 2022
SAYER KEVIN R Chairman, CEO & President
Sold, plan not stated 2×
$9.88M 22,674 at 435.56
22.4%
23 Dec 2021
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$143.48K 250 at 573.91
0.7%
15 Dec 2021
SAYER KEVIN R Chairman, CEO & President
Sold, plan not stated 14×
$1.61M 3,000 at 535.97
3.5%
13 Dec 2021
Regan Barry J. EVP Operations
Sold, plan not stated
$684.61K 1,214 at 563.93
9.6%
6 Dec 2021
Sylvain Jereme M EVP, Chief Financial Officer
Sold, plan not stated
$310.55K 600 at 517.59
4.7%
1 Dec 2021
FOLETTA MARK G Director · indirect
Sold, plan not stated 8×
$281.42K 500 at 562.83
3.8%
23 Nov 2021
Stern Sadie EVP Chief Human Resources Off
Sold, plan not stated
$731.65K 1,195 at 612.26
9.2%
23 Nov 2021
Pacelli Steven Robert Managing Dir., Dexcom Ventures
Sold, plan not stated
$153.07K 250 at 612.26
0.6%
22 Nov 2021
Stern Sadie EVP Chief Human Resources Off
Sold, plan not stated
$546.68K 856 at 638.65
6.2%
22 Nov 2021
Regan Barry J. EVP Operations
Sold, plan not stated
$534.55K 837 at 638.65
6.2%
Showing 1–50 of 471. Page 1 of 10 Older →